Author Krisam, Johannes

• 2018 | Journal Article
  ​ ​Generation of a New Disease-specific Prognostic Score for Patients With Brain Metastases From Small-cell Lung Cancer Treated With Whole Brain Radiotherapy (BMS-Score) and Validation of Two Other Indices​
  Bernhardt, D.; König, L.; Aufderstrasse, S.; Krisam, J.; Hoerner-Rieber, J.; Adeberg, S. & Bozorgmehr, F. et al.​ (2018) 
  Clinical Lung Cancer, 19(4) pp. 340​-345​.​ DOI: https://doi.org/10.1016/j.cllc.2017.12.004 
  ​Details  DOI  PMID  PMC 

• 2018 | Journal Article
  ​ ​Evaluation of Stereotactic Radiotherapy of the Resection Cavity After Surgery of Brain Metastases Compared to Postoperative Whole-Brain Radiotherapy (ESTRON)-A Single-Center Prospective Randomized Trial​
  El Shafie, R. A. ; Paul, A.; Bernhardt, D.; Hauswald, H.; Welzel, T.; Sprave, T. & Hommertgen, A. et al.​ (2018) 
  Neurosurgery, 83(3) pp. 566​-573​.​ DOI: https://doi.org/10.1093/neuros/nyy021 
  ​Details  DOI  PMID  PMC 

• 2018 | Journal Article | 
  ​ ​Whole brain radiation therapy alone versus radiosurgery for patients with 1-10 brain metastases from small cell lung cancer (ENCEPHALON Trial): study protocol for a randomized controlled trial​
  Bernhardt, D.; Hommertgen, A.; Schmitt, D.; El Shafie, R. ; Paul, A.; König, L. & Mair-Walther, J. et al.​ (2018) 
  Trials, 19(1) pp. 388​.​ DOI: https://doi.org/10.1186/s13063-018-2745-x 
  ​Details  DOI  PMID  PMC 

• 2019 | Journal Article
  ​ ​Robotic Radiosurgery for Brain Metastases Diagnosed With Either SPACE or MPRAGE Sequence (CYBER-SPACE)-A Single-Center Prospective Randomized Trial​
  El Shafie, R. A. ; Paul, A.; Bernhardt, D.; Lang, K.; Welzel, T.; Sprave, T. & Hommertgen, A. et al.​ (2019) 
  Neurosurgery, 84(1) pp. 253​-260​.​ DOI: https://doi.org/10.1093/neuros/nyy026 
  ​Details  DOI  PMID  PMC 

• 2019 | Journal Article | 
  ​ ​Fostering efficacy of anti-PD-1-treatment: Nivolumab plus radiotherapy in advanced non-small cell lung cancer - study protocol of the FORCE trial​
  Bozorgmehr, F.; Hommertgen, A.; Krisam, J.; Lasitschka, F.; Kuon, J.; Maenz, M. & Huber, P. E et al.​ (2019) 
  BMC Cancer, 19(1) pp. 1074​.​ DOI: https://doi.org/10.1186/s12885-019-6205-0 
  ​Details  DOI  PMID  PMC 

• 2020 | Journal Article
  ​ ​Efficient Adaptive Designs for Clinical Trials of Interventions for COVID-19​
  Stallard, N.; Hampson, L.; Benda, N.; Brannath, W.; Burnett, T.; Friede, T.   & Kimani, P. K. et al.​ (2020) 
  Statistics in Biopharmaceutical Research, 12(4) pp. 483​-497​.​ DOI: https://doi.org/10.1080/19466315.2020.1790415 
  ​Details  DOI 

• 2020 | Journal Article | 
  ​ ​Thoracic radiotherapy plus Durvalumab in elderly and/or frail NSCLC stage III patients unfit for chemotherapy - employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacy: study protocol of the TRADE-hypo trial​
  Bozorgmehr, F.; Chung, I.; Christopoulos, P.; Krisam, J.; Schneider, M. A.; Brückner, L. & Mueller, D. W. et al.​ (2020) 
  BMC Cancer, 20(1).​ DOI: https://doi.org/10.1186/s12885-020-07264-8 
  ​Details  DOI 

• 2022 | Journal Article | Research Paper | 
  ​ ​Protocol of the TREASURE study: Thoracic RadiothErapy with Atezolizumab in Small cell lUng canceR Extensive disease – a randomized, open-label, multicenter phase II trial​
  Bozorgmehr, F.; Christopoulos, P.; Chung, I.; Cvetkovic, J.; Feißt, M.; Krisam, J. & Schneider, M. A. et al.​ (2022) 
  BMC Cancer, 22(1) art. 1011​.​ DOI: https://doi.org/10.1186/s12885-022-10074-9 
  ​Details  DOI 

• 2023 | Journal Article
  ​ ​Treatment tolerability and toxicity of postoperative proton beam therapy for gynecological malignancies – results of the prospective phase II APROVE-trial​
  Arians, N.; Lindel, K.; Krisam, J.; Oelmann-Avendano, J. T.; Meixner, E.; König, L. & Hoerner-Rieber, J. et al.​ (2023) 
  International Journal of Radiation Oncology*Biology*Physics,.​ DOI: https://doi.org/10.1016/j.ijrobp.2023.01.004 
  ​Details  DOI 

• 2023 | Journal Article | Erratum
  ​ ​Correction: Thoracic radiotherapy plus Durvalumab in elderly and/or frail NSCLC stage III patients unfit for chemotherapy - employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacy: study protocol of the TRADE-hypo trial​
  Bozorgmehr, F.; Chung, I.; Christopoulos, P.; Krisam, J.; Schneider, M. A.; Brückner, L. & Mueller, D. W. et al.​ (2023) 
  BMC Cancer, 23(1).​ DOI: https://doi.org/10.1186/s12885-023-11270-x 
  ​Details  DOI 

• 2023 | Journal Article | 
  ​ ​Health-related quality of life and patient-reported symptoms after postoperative proton beam radiotherapy of cervical and endometrial cancer: 2-year results of the prospective phase II APROVE-trial​
  Meixner, E.; Wark, A.; Forster, T.; Weykamp, F.; Lang, K.; König, L. & Lindel, K. et al.​ (2023) 
  Radiation Oncology, 18(1) art. 5​.​ DOI: https://doi.org/10.1186/s13014-023-02198-4 
  ​Details  DOI 

Researcher

Sort

Items per Page